6:28 PM
 | 
Mar 05, 2013
 |  BC Extra  |  Financial News

Saladax raises $22.4 million in series D

Saladax Biomedical Inc. (Bethlehem, Pa.) raised $22.4 million in a series D round from Shanghai Fosun Pharmaceutical Group Co....

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >